Minoxidil vs PRP vs Finasteride for Androgenetic Alopecia
Minoxidil, platelet-rich plasma (PRP), and finasteride are commonly considered treatments for androgenetic alopecia, also called male or female pattern hair loss. However, they work differently, carry different risks, and are not appropriate for every patient.
Topical minoxidil supports follicle activity and may be used by suitable men and women. Oral finasteride reduces the production of dihydrotestosterone, or DHT, and is FDA-approved for male pattern hair loss. PRP uses a preparation derived from the patient’s blood and is administered through scalp injections in a clinical setting.
PRP preparation and treatment schedules are not fully standardized, and PRP is not FDA-approved specifically as a hair-loss treatment. Low-dose oral minoxidil, compounded topical finasteride, and several other regimens used in hair-loss clinics are also off-label or unapproved for this indication in the United States.
This guide compares their evidence, benefits, limitations, adverse effects, costs, treatment schedules, and monitoring requirements. It also explains when combination treatment may be considered.
Medical note: This article provides general educational information and does not replace diagnosis, prescribing, or treatment from a dermatologist, physician, pharmacist, or another appropriately licensed healthcare professional.
Quick Answer: Minoxidil, PRP, or Finasteride?
Topical minoxidil is an established treatment for male and female pattern hair loss. Oral finasteride is an established prescription treatment for appropriate men. PRP may improve density in some patients, but its protocols and results vary.
There is no universal winner. The most suitable option depends on the diagnosis, sex, age, pregnancy potential, medical history, severity, treatment goals, tolerance, budget, and ability to follow the treatment consistently.
Key Takeaways
- Topical minoxidil has established evidence. It may support hair growth in suitable men and women, but continued use is generally required.
- Oral finasteride targets DHT. It is FDA-approved for male pattern hair loss and requires an informed discussion about sexual, reproductive, mood, breast, and PSA considerations.
- PRP may improve density. Outcomes vary because preparation systems, platelet concentrations, injection methods, and treatment schedules differ.
- No treatment works for everyone. Diagnosis and patient-specific safety considerations must guide treatment selection.
- Combination treatment may offer additional benefit. It also increases cost, complexity, and monitoring requirements.
- Earlier assessment may preserve more active follicles. Treatment is less predictable in smooth areas affected by advanced, long-standing loss.
Quick Navigation
Not Sure Which Treatment Is Right for You?
A widening part, receding hairline, thinning crown, or gradual reduction in density may suggest androgenetic alopecia. Telogen effluvium, alopecia areata, traction alopecia, scarring alopecia, thyroid disease, nutritional deficiency, and hair breakage can cause overlapping changes.
A trichologist can assess the visible pattern, scalp condition, hair-shaft quality, routine, and treatment history. Medical diagnosis, prescription treatment, PRP injections, blood-test interpretation, and management of significant adverse effects require an appropriately licensed clinician.
What Is Androgenetic Alopecia?
Androgenetic alopecia is a common, progressive form of patterned hair loss influenced by genetics, age, androgen signaling, and follicular sensitivity.
Men commonly develop temple recession, frontal hairline loss, or crown thinning. Women more often experience a widening central part and reduced density across the top of the scalp.
DHT contributes to progressive follicular miniaturization in genetically susceptible male scalp follicles. Female pattern hair loss is more biologically complex, and many affected women have normal circulating androgen levels.
Read our complete guide to androgenetic alopecia.
Minoxidil for Androgenetic Alopecia
Minoxidil was originally developed as an oral medicine for high blood pressure. Topical formulations were subsequently developed for pattern hair loss.
Its effect is not explained by circulation alone. Minoxidil appears to influence follicular signaling and the duration of the active growth phase, although its complete hair-growth mechanism remains incompletely understood.
Topical minoxidil is available in different strengths and formulations. Low-dose oral minoxidil is prescribed by some clinicians, but its use for hair loss remains off-label in the United States and involves systemic safety considerations.
Potential Benefits of Topical Minoxidil
- May slow visible progression.
- May improve density in responsive follicles.
- May be used by suitable men and women.
- Is available without a prescription in many locations.
- Can be combined with other treatments when appropriate.
- Does not directly suppress systemic DHT when applied topically as directed.
Response varies, and meaningful regrowth is more likely where follicles remain active than in smooth areas affected by advanced follicular loss.
How Long Does Minoxidil Take to Work?
Some users notice temporary increased shedding after starting treatment. Initial improvement may become visible after three to six months, but six to twelve months of consistent use may be needed for a reasonable assessment.
Continued use is generally required to maintain the supported growth. After discontinuation, treatment-associated benefits may gradually diminish.
Possible Side Effects of Topical Minoxidil
- Scalp dryness, itching, or irritation
- Flaking or contact dermatitis
- Temporary increased shedding
- Unwanted facial or body hair
- Changes in hair texture
Systemic symptoms are uncommon with correct topical use but may include dizziness, rapid heartbeat, swelling, chest symptoms, or blood-pressure changes. Stop using the product and obtain medical advice if significant systemic symptoms develop.
Low-Dose Oral Minoxidil
Low-dose oral minoxidil is increasingly prescribed off-label for hair loss. It is a systemic prescription medicine—not a direct substitute for topical treatment.
Possible adverse effects include unwanted facial or body hair, fluid retention, ankle swelling, headache, dizziness, low blood pressure, and increased heart rate or palpitations. Appropriate medical screening and follow-up are required.
Platelet-Rich Plasma Therapy for Hair Loss
PRP treatment begins with a blood draw. The blood is processed to produce plasma containing a higher concentration of platelets, and the preparation is injected into selected areas of the scalp.
Platelets release signaling proteins and growth factors that may influence tissue repair, inflammation, blood-vessel formation, and follicle activity.
Because the preparation comes from the patient’s own blood, allergic reactions to a foreign injected substance are less likely. However, PRP is not risk-free.
Potential Benefits of PRP
- May improve hair density in some men and women with androgenetic alopecia.
- May improve hair-shaft caliber in responsive areas.
- Does not require daily application.
- Has limited systemic drug exposure.
- May complement medical or surgical treatment in suitable patients.
Systematic reviews generally suggest improvement in hair density for some patients. However, certainty is limited by small studies, variable protocols, inconsistent outcome measures, and differences between PRP preparations.
Why PRP Results Vary
- Platelet concentration
- Presence or absence of white blood cells
- Preparation and centrifugation system
- Injection depth, volume, and spacing
- Number and frequency of sessions
- Patient diagnosis and stage of loss
- Use of maintenance treatment
- Use of other hair-loss treatments
Results reported by one clinic or study cannot automatically be applied to every PRP system or treatment schedule.
Typical PRP Treatment Schedule
Many clinics begin with a short series of sessions, sometimes one treatment per month for approximately three months, followed by less frequent maintenance. However, no single schedule has been established as best for every patient.
Possible Risks and Limitations of PRP
- Injection pain and scalp tenderness
- Temporary swelling or bruising
- Pinpoint bleeding
- Headache
- Temporary shedding
- Infection if appropriate sterile technique is not followed
- Variable response
- Higher cost and time commitment than most home treatments
People with certain blood, platelet, clotting, infectious, or other medical conditions may not be suitable candidates. Medicines and supplements that affect bleeding or platelet activity should be reviewed before treatment.
Finasteride for Androgenetic Alopecia
Finasteride inhibits type II 5-alpha-reductase and reduces the conversion of testosterone to DHT.
Oral finasteride 1 mg is FDA-approved for male pattern hair loss. It is not FDA-approved for hair loss in women. Specialist off-label use may occur in selected women, but pregnancy potential, contraception, age, hormonal status, and medical history require careful assessment.
Potential Benefits of Finasteride
- Targets an important driver of male androgenetic alopecia.
- May slow or stabilize follicular miniaturization.
- May improve hair count and scalp coverage in some men.
- Uses a once-daily oral schedule.
- Can be combined with topical minoxidil when appropriate.
Benefit may become noticeable after several months, although a fuller assessment commonly requires approximately twelve months. Continued treatment is generally needed to maintain its effect.
Finasteride Safety Considerations
Read our detailed guide to finasteride side effects and blood testing.
Reported adverse effects and safety considerations include:
- Reduced libido
- Erectile or ejaculation changes
- Changes in semen measures or fertility in susceptible patients
- Breast tenderness or enlargement
- Testicular discomfort
- Mood changes or depression
- Allergic reactions
- Changes in PSA levels
These effects are not experienced by most users, but they should be reviewed before treatment. Persistent sexual, reproductive, neurological, or psychological symptoms reported during or after treatment deserve appropriate medical assessment.
Finasteride and Pregnancy
Finasteride can interfere with the normal external genital development of a male fetus. It must not be used during pregnancy. Pregnant people or those who may be pregnant should not handle crushed or broken finasteride tablets.
Intact coated tablets are designed to prevent contact with the active ingredient during ordinary handling.
Finasteride and PSA Testing
Finasteride can lower prostate-specific antigen levels. The clinician interpreting a PSA result must know that the patient takes finasteride so the result can be assessed appropriately.
Are Blood Tests Required Before Finasteride?
No validated blood test can reliably predict whether a person will develop finasteride adverse effects.
Routine laboratory testing is not required for every healthy man. Targeted testing may be considered when age, symptoms, medical history, fertility goals, medicines, or prostate, liver, or endocrine concerns justify it.
Minoxidil vs PRP vs Finasteride: Comparison
| Factor | Minoxidil | PRP | Finasteride |
|---|---|---|---|
| Main action | Supports follicle activity and growth-cycle signaling | Delivers concentrated platelets and signaling proteins | Reduces conversion of testosterone to DHT |
| U.S. regulatory status | Topical formulations are approved for pattern hair loss; oral use is off-label | Not FDA-approved specifically for hair loss | Oral 1 mg is approved for male pattern hair loss; compounded topical products are not FDA-approved |
| Typical candidates | Suitable men and women | Selected men and women with active follicles | Primarily adult men with confirmed AGA |
| Administration | Daily topical application; oral treatment is prescription and off-label | In-clinic scalp injections | Daily prescription tablet |
| Assessment period | Usually 6–12 months | Several months after an initial treatment series | Usually 6–12 months |
| Main concerns | Irritation, shedding, unwanted facial hair; systemic effects with oral use | Pain, bleeding, infection, cost, and variable protocols | Sexual, reproductive, mood, breast, pregnancy, and PSA considerations |
| Typical cost | Low to moderate | Usually higher because repeated clinical sessions may be required | Low to moderate |
| Maintenance | Ongoing use is generally needed | Maintenance sessions may be recommended | Ongoing use is generally needed |
Which Treatment Is Most Effective?
There is no universal winner.
Oral finasteride has established evidence for slowing male androgenetic alopecia because it reduces DHT. Topical minoxidil has established use in both male and female pattern hair loss.
PRP may improve density in selected patients with active miniaturized follicles, but comparisons are complicated by differences between PRP products and treatment protocols.
The most appropriate treatment is one that matches the diagnosis, has an acceptable safety profile, can be followed consistently, and produces measurable benefit.
Minoxidil vs Finasteride
Finasteride targets DHT, while minoxidil supports follicular activity. In appropriate men, combination treatment may provide greater benefit than either treatment alone.
Topical minoxidil can also be considered by suitable women and does not require systemic DHT suppression. Treatment selection should not be based solely on convenience or expected efficacy; safety and patient preference also matter.
PRP vs Minoxidil
Direct comparisons have produced mixed results. Some trials favor PRP for selected measures, while others show benefit from both treatments without establishing a definitive winner.
Minoxidil is generally less expensive and can be used at home. PRP avoids daily application but requires scalp injections, repeated appointments, and a larger budget.
PRP vs Finasteride
These treatments work through different pathways. Finasteride reduces DHT in men, while PRP supplies local platelet-derived signals.
PRP may be considered by people who cannot or prefer not to use finasteride, but it should not be represented as an equivalent DHT-lowering treatment.
Combination Treatment
Combination treatment attempts to address more than one part of androgenetic alopecia. However, adding more treatments does not automatically create a better plan.
Each component should have a defined purpose, realistic benefit, acceptable risk, and clear method for assessing response.
Minoxidil Plus Finasteride
This combination is commonly considered for appropriate men. Finasteride reduces DHT, while minoxidil supports follicle activity. Evidence suggests that combination treatment may outperform either treatment alone for some patients.
The combination does not eliminate the individual adverse effects or monitoring requirements of either treatment.
PRP Plus Minoxidil
PRP may be added to topical minoxidil when a patient wants a clinical procedure alongside home treatment. Evidence suggests possible additional benefit, but study quality and PRP protocols vary.
PRP Plus Finasteride
PRP and finasteride may be used together in selected men. Finasteride addresses DHT-related progression, while PRP provides local platelet-derived signals. Evidence does not support describing this as the universal standard for every patient.
Using All Three Treatments
Some patients use minoxidil, PRP, and finasteride together. This may be considered after reviewing diagnosis, safety, cost, treatment burden, and monitoring needs.
If one component provides no measurable value after an appropriate assessment period, continuing it indefinitely may not be justified.
Alternatives and Additional Treatments
Microneedling
Microneedling creates controlled punctures in the scalp and may stimulate wound-healing signals or improve response to topical treatment.
Needle depth, technique, frequency, hygiene, and products applied afterward materially affect safety. Incorrect home use can cause infection, irritation, scarring, or worsening inflammation.
Learn more about microneedling and PRP.
Hair Transplantation
Hair transplantation moves suitable follicles from a donor region into an area with reduced density.
It does not stop untreated native follicles from continuing to miniaturize. Long-term planning and maintenance treatment may therefore remain important.
Low-Level Light Therapy
Low-level light therapy uses selected red or near-infrared wavelengths. Some devices have supportive evidence, but device quality, dose, schedule, and adherence vary.
Dutasteride
Dutasteride inhibits type I and type II 5-alpha-reductase and generally suppresses DHT more extensively than finasteride.
It is not FDA-approved for hair loss in the United States, although its regulatory status differs internationally. Read our guide to dutasteride vs finasteride.
How to Choose Between Minoxidil, PRP, and Finasteride
Minoxidil May Be Considered When
- A suitable man or woman has confirmed pattern hair loss.
- A home treatment is preferred.
- Systemic DHT suppression is not desired.
- The patient accepts consistent, ongoing treatment.
- The scalp tolerates the selected formulation.
PRP May Be Considered When
- The diagnosis has been confirmed.
- Active miniaturized follicles remain.
- A clinic-based procedure is acceptable.
- Cost and maintenance requirements are understood.
- No relevant medical, blood, platelet, or clotting contraindication is present.
Finasteride May Be Considered When
- An adult man has confirmed androgenetic alopecia.
- Reducing DHT-related progression is a priority.
- Benefits, risks, and alternatives have been reviewed.
- Pregnancy exposure has been considered.
- Relevant sexual, reproductive, mood, breast, fertility, prostate, and medical factors have been discussed.
Why Treatment May Not Work as Expected
- The original diagnosis is incorrect.
- Treatment begins after advanced follicular loss.
- The treatment is used inconsistently.
- The assessment period is too short.
- Another type of hair loss is also present.
- Scarring has permanently damaged follicles.
- Iron deficiency, thyroid disease, illness, medicine, or another factor causes additional shedding.
- The formulation or PRP protocol is unsuitable.
- Progress is assessed without standardized photographs.
Avoid changing treatments every few weeks. Establish a baseline, use an appropriate review period, and monitor both benefit and adverse effects.
How to Track Treatment Progress
- Take baseline photographs. Include the hairline, temples, central part, top, and crown.
- Standardize every photograph. Use consistent lighting, hairstyle, camera angle, and distance.
- Record each treatment. Note the product, dose, frequency, and starting date.
- Track adverse effects. Record scalp reactions and relevant systemic symptoms.
- Compare every few months. Daily photographs or mirror checks are too variable.
- Review the entire plan. Determine whether each treatment provides enough value to justify its risk, cost, and inconvenience.
When to See a Trichologist or Dermatologist
Consider a trichology assessment if you cannot distinguish pattern thinning from shedding or breakage, need consistent photographs, or want help reviewing scalp care and treatment adherence.
Seek assessment from a dermatologist or another appropriately licensed clinician when:
- Hair loss is sudden, patchy, painful, inflamed, or rapidly progressive.
- The scalp develops pustules, bleeding, crusting, or smooth scar-like areas.
- A prescription systemic treatment is being considered.
- PRP injections, blood testing, or a scalp biopsy may be required.
- Sexual, psychological, cardiovascular, breast, fertility, or prostate symptoms occur.
- Pregnancy, liver disease, cardiovascular disease, or another significant condition is relevant.
Find a Trichologist Near You
Not sure whether your hair loss is androgenetic alopecia, telogen effluvium, traction alopecia, breakage, or another condition?
A professional assessment can document the visible pattern, evaluate scalp and hair-shaft health, and help identify the most appropriate next step.
Related Hair-Loss Treatment Guides
Frequently Asked Questions
- Which treatment is best for androgenetic alopecia?
- No treatment is best for everyone. The choice depends on diagnosis, sex, age, severity, medical history, pregnancy potential, tolerance, cost, and treatment goals.
- Is PRP better than minoxidil?
- Some studies favor PRP for selected outcomes, while others find both treatments helpful. Minoxidil is generally less expensive and used at home; PRP requires injections and clinical appointments.
- Is finasteride better than minoxidil?
- Finasteride targets DHT-related progression in appropriate men. Minoxidil supports follicular activity and can be considered by suitable men and women. They may also be combined.
- Can PRP permanently cure androgenetic alopecia?
- No. PRP may improve density in responsive follicles, but androgenetic alopecia is chronic and maintenance treatment may be required.
- Can these treatments restore a completely bald area?
- Regrowth is less predictable where follicles have been severely depleted or inactive for a long time. Treatment is generally more effective at preserving or strengthening active follicles.
- Can minoxidil and finasteride be used together?
- Yes, in suitable patients under appropriate guidance. Evidence suggests that the combination may outperform either treatment alone in some men.
- Can PRP and minoxidil be combined?
- Yes. The combination may offer additional benefit for some patients, although PRP protocols and individual responses vary.
- Can minoxidil, PRP, and finasteride all be used together?
- Some patients use all three. The additional cost, burden, risks, and monitoring requirements should be considered before starting a multi-treatment plan.
- How long does minoxidil take to work?
- Initial changes may appear after three to six months, but six to twelve months may be required for a fair assessment.
- How long does finasteride take to work?
- Some men notice stabilization or early improvement after several months. A fuller assessment often requires approximately twelve months.
- How long does PRP take to work?
- Changes may become visible several months after the initial treatment series. Timing depends on the protocol, diagnosis, and individual response.
- What happens after stopping minoxidil or finasteride?
- The supported benefit may gradually diminish, and androgenetic alopecia may continue progressing.
- What are the primary risks of PRP?
- Possible risks include pain, tenderness, swelling, bruising, bleeding, headache, temporary shedding, and infection.
- Can a blood test predict finasteride side effects?
- No validated blood test reliably predicts who will experience adverse effects. Targeted testing may still be useful when specific medical, fertility, hormonal, liver, or prostate concerns exist.
- Can women take finasteride?
- Finasteride is not FDA-approved for female pattern hair loss. Specialist off-label use may occur in carefully selected women, but pregnancy risk and other medical considerations require close supervision.
Conclusion
Minoxidil, PRP, and finasteride can each play a role in managing androgenetic alopecia, but they differ substantially in evidence, risks, costs, and practical requirements.
Topical minoxidil is accessible and has established use in suitable men and women. Oral finasteride reduces DHT and has established evidence for appropriate men. PRP provides a non-drug, clinic-based option that may improve density in selected patients, although protocols and outcomes vary.
Combination treatment may provide additional benefit, but every component should have a clear purpose and acceptable safety profile.
Most importantly, confirm the diagnosis before starting treatment. Sudden shedding, bald patches, inflammation, scalp pain, scarring, or rapid progression may indicate another condition.
Next step: Read our guide to androgenetic alopecia, review finasteride safety and blood testing, or find a trichologist near you.
References and Further Reading
- U.S. Food and Drug Administration: Propecia prescribing information.
- FDA: Potential risks associated with compounded topical finasteride.
- Minoxidil: A comprehensive review.
- Low-dose oral minoxidil initiation for patients with hair loss: expert consensus.
- The role of platelet-rich plasma in androgenetic alopecia.
- Platelet-rich plasma for androgenetic alopecia: systematic review and meta-analysis.
- The additive value of platelet-rich plasma to topical minoxidil.
- Finasteride, minoxidil, and combination treatment in male androgenetic alopecia.
- Finasteride combined with topical minoxidil for androgenetic alopecia.
- Cleveland Clinic: Male and female pattern hair-loss treatment.
Medical disclaimer: This article is for general informational and educational purposes only. It does not provide medical advice, diagnosis, prescribing, or a personalized recommendation to use minoxidil, PRP, finasteride, dutasteride, a device, injection, or procedure. Regulatory approval and prescribing rules differ by formulation, indication, sex, and country. Seek professional assessment for sudden, patchy, painful, inflamed, scar-like, or rapidly progressive hair loss. Obtain prompt medical advice for significant sexual, psychological, cardiovascular, breast, fertility, pregnancy, or prostate-related concerns.